Down‐regulation of SMURF1 inhibits ovarian cancer invasion and EMT (Epithelial‐mesenchymal transition) process through modulation on DAB2IP/AKT/Skp2 axis. This evidence concerns the gene SMURF1 and ovarian cancer.